Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on May 01, 2024 on account of Maharashtra Day.

Smallcaps in the limelight
Mon, 11 Oct 01:30 pm

Indian indices lost their opening gains on profit booking in heavy weights over the previous two hours of trade. Stocks from the metal and auto space are trading firm while stocks from the IT and power space are trading weak.

The BSE-Sensex is up by 33 points while NSE-Nifty is trading 8 points above the dotted line. BSE-Midcap is up by 0.6% while BSE-Smallcap index is trading 1.2% above Friday's closing. The rupee is trading at 44.40 to the US dollar.

Healthcare stocks are trading mixed with Ranbaxy and Glenmark Pharma trading in the green and Apollo Hospital and Biocon trading in the red. As per a leading financial daily, Cadila Healthcare is expected to benefit from the French government's cost saving measures. The French government recently announced plans to save EUR 860 m next year through price cuts on medicines and medical devices and measures to encourage use of generic or off-patent medicines. This move forms part of France's plan to save EUR 2.4 bn its social security for financing. Cadila being the only Indian company with a serious presence in France, is expected to make significant gains from this. It may be recalled that Cadila had seen a growth of 31% YoY from France in FY10.

Auto stocks are trading mixed with Tata Motors and Hero Honda trading firm while Force Motors and Escorts were trading weak. As per a leading financial daily, the production of Nano cars is expected to climb to 8,000 - 9,000 units in the next two-three months as production at the dedicated manufacturing plant at Sanand is ramped up. It may be noted that the production of the cars had fallen in September as the company had stopped making the car at the Pantnagar plant and shifted production entirely to its Sanand facility. The Sanand plant has a capacity of 240,000 units per annum. However, according to a company official the whole supply chain is to be fully in place before the company ramps up production. As of now, some of the he component suppliers for the Sanand plant are yet to be fully operational.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Smallcaps in the limelight". Click here!

1 Responses to "Smallcaps in the limelight"

Sanjay Gokhalw

Oct 11, 2010

Please smallcap share Tips

Like 
  
Equitymaster requests your view! Post a comment on "Smallcaps in the limelight". Click here!
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.